Abstract
The incidence of breast cancer (BC) in postmenopausal women is continuously rising. Due to early diagnosis and various treatment designs, the long-term clinical outcome has improved. Frequent settings are chemotherapy as well as endocrine treatment. Both have proven to interfere with bone health resulting in cancer treatment-induced bone loss (CTIBL). Whereas chemotherapy is associated with increased bone resorption, aromatase inhibitor (AI) therapy reduces residual estrogen and is associated with decreased bone mineral density. Independent of the AI administered, the loss of bone mineral density is twice as high compared to healthy postmenopausal women. As a consequence of CTIBL, both chemotherapy and AI treatment can lead to a significantly increased fracture risk. Therefore, several guidelines have emerged for the management of CTIBL in women with BC, including strategies to identify and treat those at high risk for fractures. Further research on tracking guideline adherence examining the feasibility and practicability of guideline implementation to bridge the gap between determined scientific best evidence and applied best practice is needed to adjust these guidelines in the future.
Citations
Oct 31, 2015·Climacteric : the Journal of the International Menopause Society·F Milat, A J Vincent
Jun 28, 2016·Climacteric : the Journal of the International Menopause Society·M KalderP Hadji
Aug 9, 2016·Clinical Breast Cancer·Susan R Harris
Jul 14, 2016·Journal of Oncology Practice·Jingyan YangDawn L Hershman
Feb 9, 2018·International Journal of Molecular Sciences·Chia-Ming FanCory J Xian
Jan 22, 2018·Calcified Tissue International·Catherine HandforthJanet Brown
Mar 20, 2020·Journal of Bone Metabolism·Seeyoun LeeKyung-Hoi Koo
May 15, 2020·Journal of Bone and Mineral Metabolism·Sung Hye KongChan Soo Shin
Jul 23, 2018·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·I KyvernitakisP Hadji
May 29, 2018·Molecular and Clinical Oncology·Christian Tang AxelsenTroels Bechmann
Apr 25, 2017·CA: a Cancer Journal for Clinicians·Heather GreenleeDebu Tripathy
Aug 18, 2020·Clinical Breast Cancer·Do Wook KimKyung Hwan Shin
Jan 23, 2021·RSC Medicinal Chemistry·Vítor YangNuno Vale
Oct 15, 2020·PloS One·So Hyun ParkHee Kyung Ahn
Aug 17, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Aliyu MuhammadIbrahim Babangida Abubakar
Aug 15, 2019·Oncology·Nicole ZulaufGerhard Maximilian Oremek